Golvatinib (E7050)
产品编号: DC5065
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Golvatinib (E-7050) 是 c-Met 和 VEGFR2 的双重抑制剂，IC50值分别为14 和 16 nM。
| Cas No.: |
928037-13-2 |
| 名称: |
|
| 别名: |
E-7060,E7050,E 7050 |
| SMILES: |
CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F |
| 分子式: |
C33H37F2N7O4 |
| 分子量: |
633.69 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
golvatinib (also known as E7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_1421_DC5065_928037-13-2 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
